Rhodium, Iridium, and Ruthenium Half-Sandwich Picolinamide Complexes as Anticancer Agents
- 7 January 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 53 (2) , 727-736
Abstract
Novel rhodium, iridium, and ruthenium half-sandwich complexes containing (N,N)-bound picolinamide ligands have been prepared for use as anticancer agents. The complexes show promising cytotoxicities, with the presence, position, and number of halides having a significant effect on the corresponding IC50 values. One ruthenium complex was found to be more cytotoxic than cisplatin on HT-29 and MCF-7 cells after 5 days and 1 h, respectively, and it remains active with MCF-7 cells even under hypoxic conditions, making it a promising candidate for in vivo studies.Keywords
This publication has 41 references indexed in Scilit:
- Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binderChemical Communications, 2012
- A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell LinesJournal of Medicinal Chemistry, 2012
- Ruthenium–Arene Complexes of Curcumin: X-Ray and Density Functional Theory Structure, Synthesis, and Spectroscopic Characterization, in Vitro Antitumor Activity, and DNA Docking Studies of (p-Cymene)Ru(curcuminato)chloroJournal of Medicinal Chemistry, 2012
- Conjugation of Organoruthenium(II) 3-(1H-Benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and Indolo[3,2-d]benzazepines to Recombinant Human Serum Albumin: a Strategy To Enhance Cytotoxicity in Cancer CellsInorganic Chemistry, 2011
- From hydrolytically labile to hydrolytically stable RuII–arene anticancer complexes with carbohydrate-derived co-ligandsJournal of Inorganic Biochemistry, 2011
- Amide Linkage Isomerism As an Activity Switch for Organometallic Osmium and Ruthenium Anticancer ComplexesJournal of Medicinal Chemistry, 2009
- Arene Control over Thiolate to Sulfinate Oxidation in Albumin by Organometallic Ruthenium Anticancer ComplexesChemistry – A European Journal, 2009
- Bioorganometallic chemistry—from teaching paradigms to medicinal applicationsChemical Society Reviews, 2008
- Using coordination chemistry to design new medicinesCoordination Chemistry Reviews, 2007
- From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)Journal of Inorganic Biochemistry, 2006